Latest News

Journal Articles

Bacterial

Countries with previous TB vaccine coverage show improved COVID-19 outcomes

How can bacterial toxins evolve to infect different tissues?

Could RBX2660 be the microbiome-based solution to C. diff infection recurrence?

Clostridium Difficile Infection

How can bacterial toxins evolve to infect different tissues?

Could RBX2660 be the microbiome-based solution to C. diff infection recurrence?

FDA approves Merck & Co.’s Ebola vaccine Ervebo: January’s industry headlines

E. Coli

Antibodies from maternal microbiota could protect newborns from infection

Multidrug efflux systems: information on evolution and mechanisms uncovered

E. coli created with world’s first synthetic and redesigned genome

H. Pylori

Organoids: a new model to study infectious diseases?

Infographic: The microbiome and infectious diseases

Are flies a significant method of bacterial transmission?

MRSA

The race for COVID-19 treatments and vaccines: February’s industry headlines

New study reveals how the household environment influences MRSA spread

Novel vaccine candidate for Staphylococcus aureus shows 80% efficacy in mice

Salmonella

Whole-genome sequencing of Salmonella enterica Serovar Typhi reveals new antimicrobial resistant isolates

Novel models for enteric infections – an interview with the Faherty Lab

Infographic: The burden of foodborne diseases

Tuberculosis

Countries with previous TB vaccine coverage show improved COVID-19 outcomes

The role of humoral immunity in TB defense – an interview with Babak Javid

Changing the administration of the BCG vaccine could improve efficacy

Fungal

A peek behind the paper – Elvira Román on CRISPR technology in pathogenic fungi

The best of 2019 – an A–Z of infectious diseases research

A peek behind the paper – Shujuan Sun on using existing antibiotics as antifungals

Aspergillosis

Fungal biofilm morphology impacts disease progression

#TalkFungi – catch up on the Twitter chat for Fungal Awareness Week

Novel antifungal presents opportunities for treating aspergillosis

Candidiasis

A peek behind the paper – Elvira Román on CRISPR technology in pathogenic fungi

A peek behind the paper – Shujuan Sun on using existing antibiotics as antifungals

Could climate change have contributed to Candida auris emergence?

Coccidioidomycosis

#TalkFungi – catch up on the Twitter chat for Fungal Awareness Week

Identification of membrane proteome of Paracoccidioides lutzii and its regulation by zinc

CNS fungal infections

Cryptococcal Meningitis

#TalkFungi – catch up on the Twitter chat for Fungal Awareness Week

Cryptococcal meningitis – taking a closer look at treatment

Infographic: Fungal infections – the hidden burden

Parasitic

Malaria parasites resistant to artemisinin now prevalent in Africa

Using a novel approach for malaria vaccine development – an interview with Jonathan Kurtis

Malaria: triple artemisinin-based combination therapies safe and effective

Helminthic Infections

Conference report – London Centre for Neglected Tropical Disease Research Anniversary Event

ISNTD – Female Genital Schistosomiasis: The most neglected gynaecological disease

Conference report – British Society for Parasitology Autumn Symposium

Malaria

Malaria parasites resistant to artemisinin now prevalent in Africa

Using a novel approach for malaria vaccine development – an interview with Jonathan Kurtis

Malaria: triple artemisinin-based combination therapies safe and effective

Neglected Tropical Diseases

Novel parasites and understanding parasite–host interactions – an interview with Sandra Maruyama

Mice, introduced by maritime trade, play a key role in Toxoplasma gondii distribution

Diagnostics for human schistosomiasis: the way forward

Protozoan Infections

Malaria: triple artemisinin-based combination therapies safe and effective

World Malaria Report 2019: a focus on pregnant women and children

Imaging study reveals how malaria parasites bypass antimalarial drugs

Viral

Countries with previous TB vaccine coverage show improved COVID-19 outcomes

The genetic basis for a high level in clinical variability among COVID-19 patients – an interview with Alessandra Renieri

Asymptomatic COVID-19 patients still carry the same amount of virus

Hepatitis

FDA approves Merck & Co.’s Ebola vaccine Ervebo: January’s industry headlines

US FDA warns of serious liver injury linked to hepatitis C drugs: September’s industry headlines

BioMalPar XV: Biology and Pathology of the Malaria Parasite

Herpes

ASM Microbe: What consequences could lifelong Epstein–Barr virus infection have for the brain?

HR-HPV oral infection rates in England are lower than expected

A peek behind the paper – Lynn Enquist on the lifecycle of alpha herpesvirus